Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control
- PMID: 28917587
- PMCID: PMC5693228
- DOI: 10.1016/j.jocn.2017.08.023
Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control
Abstract
We report a single institution series of surgery followed by either early adjuvant or late radiotherapy for atypical meningiomas (AM). AM patients, by WHO 2007 definition, underwent subtotal resection (STR) or gross total resection (GTR). Sixty-three of a total 115 patients then received fractionated or stereotactic radiation treatment, early adjuvant radiotherapy (≤4months after surgery) or late radiotherapy (at the time of recurrence). Kaplan Meier method was used for survival analysis with competing risk analysis used to assess local failure. Overall survival (OS) at 1, 2, and 5years for all patients was 87%, 85%, 66%, respectively. Progression free survival (PFS) at 1, 2, and 5years for all patients was 65%, 30%, and 18%, respectively. OS at 1, 2, and 5years was 75%, 72%, 55% for surgery alone, and 97%, 95%, 75% for surgery+radiotherapy (log-rank p-value=0.0026). PFS at 1, 2, and 5years for patients undergoing surgery without early adjuvant radiotherapy was 64%, 49%, and 27% versus 81%, 73%, and 59% for surgery+early adjuvant radiotherapy (log-rank p-value=0.0026). The cumulative incidence of local failure at 1, 2, and 5years for patients undergoing surgery without early External Beam Radiation Therapy (EBRT) was 18.7%, 35.0%, and 52.9%, respectively, versus 4.2%, 13.3%, and 20.0% for surgery and early EBRT (p-value=0.02). Adjuvant radiotherapy improves OS in patients with AM. Early adjuvant radiotherapy improves PFS, likely due to the improvement in local control seen with early adjuvant EBRT.
Keywords: Atypical meningioma; Early; Late; Radiotherapy.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Figures





Similar articles
-
Early adjuvant radiotherapy in the treatment of atypical meningioma.J Clin Neurosci. 2016 Jun;28:87-92. doi: 10.1016/j.jocn.2015.09.021. Epub 2016 Jan 8. J Clin Neurosci. 2016. PMID: 26775147
-
Adjuvant radiotherapy for atypical meningiomas.J Neurosurg. 2017 Jun;126(6):1822-1828. doi: 10.3171/2016.5.JNS152809. Epub 2016 Sep 9. J Neurosurg. 2017. PMID: 27611201
-
Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.J Neurosurg. 2018 Apr 6;130(2):443-450. doi: 10.3171/2017.9.JNS171609. J Neurosurg. 2018. PMID: 29624151
-
Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: a systematic review and meta-analysis.Radiat Oncol. 2021 Feb 17;16(1):34. doi: 10.1186/s13014-021-01759-9. Radiat Oncol. 2021. PMID: 33596974 Free PMC article.
-
Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.J Neurooncol. 2021 Apr;152(2):205-216. doi: 10.1007/s11060-020-03674-7. Epub 2021 Feb 26. J Neurooncol. 2021. PMID: 33635510 Review.
Cited by
-
Radiation therapy for atypical and anaplastic meningiomas: an overview of current results and controversial issues.Neurosurg Rev. 2022 Oct;45(5):3019-3033. doi: 10.1007/s10143-022-01806-3. Epub 2022 Jun 4. Neurosurg Rev. 2022. PMID: 35665867 Free PMC article. Review.
-
Cost-Effectiveness Analysis of 68Ga-DOTATATE PET/MRI in Radiotherapy Planning in Patients with Intermediate-Risk Meningioma.AJNR Am J Neuroradiol. 2023 Jul;44(7):783-791. doi: 10.3174/ajnr.A7901. Epub 2023 Jun 8. AJNR Am J Neuroradiol. 2023. PMID: 37290818 Free PMC article.
-
Postoperative Adjuvant Radiotherapy in Atypical Meningioma Patients: A Meta-Analysis Study.Front Oncol. 2021 Dec 2;11:787962. doi: 10.3389/fonc.2021.787962. eCollection 2021. Front Oncol. 2021. PMID: 34926303 Free PMC article.
-
Impact of radiotherapy in atypical meningioma recurrence: literature review.Neurosurg Rev. 2019 Sep;42(3):631-637. doi: 10.1007/s10143-018-0959-8. Epub 2018 Mar 19. Neurosurg Rev. 2019. PMID: 29552691 Review.
-
Rethinking the effects of adjuvant beam radiation therapy on overall survival in atypical meningioma patients: age considerations.Front Neurol. 2024 Mar 15;15:1360741. doi: 10.3389/fneur.2024.1360741. eCollection 2024. Front Neurol. 2024. PMID: 38560728 Free PMC article.
References
-
- Messerer M, Richoz B, Cossu G, Dhermain F, Hottinger AF, Parker F, et al. Recent advances in the management of atypical meningiomas. Neurochirurgie. 2016 http://dx.doi.org/10.1016/j.neuchi.2016.02.003. - DOI - PubMed
-
- Pearson BE, Markert JM, Fisher WS, Guthrie BL, Fiveash JB, Palmer CA, et al. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. Neurosurg Focus. 2008;24:E3. - PubMed
-
- Hug EB, Devries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, et al. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol. 2000;48:151–60. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources